• STAT+: Money troubles and M&A: What's on biotech insiders' minds ahead of a not-so-celebratory JPM week

    23 days ago - By STAT

    SAN FRANCISCO - What should be a triumphant return to the global biotech industry's biggest annual event, “JPM Week,” after a two-year hiatus is turning as gloomy as Bay Area weather, with industry executives forecasting economic troubles in the year ahead.
    STAT asked more than 100 biotech and pharma executives, investors, and other insiders how they're feeling about the state of the sector heading into 2023 and on the eve of the J.P. Morgan Healthcare Conference in San Francisco. The biggest takeaway: Nearly 70% of respondents said financing - raising venture capital, launching an IPO, or...
    Read more ...